Challenges and perspectives for improved management of HIV/Mycobacterium tuberculosis co-infection.
HIV and Mycobacterium tuberculosis (MTB) are two widespread and highly successful microbes whose synergy in pathogenesis has created a significant threat for human health globally. In acknowledgement of this fact, the European Union (EU) has funded a multinational support action, the European Network for global cooperation in the field of AIDS and TB (EUCO-Net), that brings together experts from Europe and those regions that bear the highest burden of HIV/MTB co-infection. Here, we summarise the main outcome of the EUCO-Net project derived from an expert group meeting that took place in Stellenbosch (South Africa) (AIDS/TB Workshop on Research Challenges and Opportunities for Future Collaboration) and the subsequent discussions, and propose priority areas for research and concerted actions that will have impact on future EU calls.
Dept of Transplant and Infection Immunology, Institute of Virology, University of the Saarland, Homburg, Germany.
M
M
Sester
C
C
Giehl
R
R
McNerney
B
B
Kampmann
G
G
Walzl
P
P
Cuchí
C
C
Wingfield
C
C
Lange
G B
GB
Migliori
A L
AL
Kritski
A
A
Meyerhans
D016915:AIDS Vaccines / Q000627:therapeutic use; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D000995:Antitubercular Agents / Q000627:therapeutic use*; D015897:Comorbidity; D003226:Congresses as Topic; D005060:Europe; D005260:Female; D006126:Group Processes; D015658:HIV Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D006287:Health Planning Guidelines; D006801:Humans; D008297:Male; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000302:isolation & purification; D032581:Tuberculosis Vaccines / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology
D016915:AIDS Vaccines; D019380:Anti-HIV Agents; D000995:Antitubercular Agents; D032581:Tuberculosis Vaccines